NOVUS THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by NOVUS THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14BIOTECHNOLOGY VALUE FUND L PEledon Pharmaceuticals, Inc.2,330,4189.6%EDGAR
SC 13G/A2024-02-14Cormorant Asset Management, LPEledon Pharmaceuticals, Inc.0-EDGAR
SC 13G2024-02-14ARMISTICE CAPITAL, LLCEledon Pharmaceuticals, Inc.2,442,74210.0%EDGAR
SC 13G/A2023-02-14Cormorant Asset Management, LPEledon Pharmaceuticals, Inc.1,391,663-EDGAR
SC 13G/A2022-02-14Cormorant Asset Management, LPEledon Pharmaceuticals, Inc.1,428,598-EDGAR
SC 13G/A2022-02-11Woodline Partners LPEledon Pharmaceuticals, Inc.685,2734.8%EDGAR
SC 13G/A2022-02-10ADAGE CAPITAL PARTNERS GP, L.L.C.Eledon Pharmaceuticals, Inc.00.0%EDGAR
SC 13G/A2022-02-09FMR LLCEledon Pharmaceuticals, Inc.504,3713.5%EDGAR
SC 13G/A2022-01-28BIOTECHNOLOGY VALUE FUND L PEledon Pharmaceuticals, Inc.1,274,9739.3%EDGAR
SC 13G/A2022-01-26Logos Global Management LPEledon Pharmaceuticals, Inc.-0.0%EDGAR
SC 13G/A2022-01-11BIOTECHNOLOGY VALUE FUND L PEledon Pharmaceuticals, Inc.791,3415.5%EDGAR
SC 13G/A2022-01-11BIOTECHNOLOGY VALUE FUND L PEledon Pharmaceuticals, Inc.734,4295.1%EDGAR
SC 13G/A2021-09-09Logos Global Management LPEledon Pharmaceuticals, Inc.1,339,7939.4%EDGAR
SC 13G/A2021-02-16BIOTECHNOLOGY VALUE FUND L PEledon Pharmaceuticals, Inc.1,014,8796.8%EDGAR
SC 13G/A2021-02-16683 Capital Management, LLCEledon Pharmaceuticals, Inc.35,900-EDGAR
SC 13G2021-02-16Woodline Partners LPEledon Pharmaceuticals, Inc.814,7565.4%EDGAR
SC 13G2021-02-08FMR LLCEledon Pharmaceuticals, Inc.1,004,1116.6%EDGAR
SC 13D/A2021-01-05OrbiMed Israel BioFund GP Limited PartnershipEledon Pharmaceuticals, Inc.73,6500.5%EDGAR
SC 13G2021-01-04ADAGE CAPITAL PARTNERS GP, L.L.C.Eledon Pharmaceuticals, Inc.892,5555.9%EDGAR
SC 13G2021-01-04Cormorant Asset Management, LPEledon Pharmaceuticals, Inc.1,415,500-EDGAR
External links